PSNL Valuation
Personalis Inc
$
4.960
- Overview
- Forecast
- Valuation
PSNL Relative Valuation
PSNL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PSNL is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for PSNL's competitors is 2.23, providing a benchmark for relative valuation. Personalis Inc Corp (PSNL) exhibits a P/S ratio of 5.11, which is 128.91% above the industry average. Given its robust revenue growth of 5.53%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
SPMC
Sound Point Meridian Capital Inc
18.270
USD
-0.71%
DGICA
Donegal Group Inc
20.610
USD
-1.20%
KALV
Kalvista Pharmaceuticals Inc
12.240
USD
+1.41%
OFLX
Omega Flex Inc
34.050
USD
-3.05%
KMDA
Kamada Ltd
6.870
USD
+0.73%
HYLN
Hyliion Holdings Corp
1.260
USD
-5.97%
NRC
National Research Corp
13.800
USD
-1.22%
MTRX
Matrix Service Co
12.680
USD
-0.78%
PKST
Peakstone Realty Trust
12.300
USD
-0.89%
OTLY
Oatly Group AB (publ)
10.260
USD
+3.12%
FAQ
Is Personalis Inc (PSNL) currently overvalued or undervalued?
Personalis Inc (PSNL) is now in the Fair zone, suggesting that its current forward PS ratio of 5.11 is considered Fairly compared with the five-year average of 5.72. The fair price of Personalis Inc (PSNL) is between 0.94 to 8.94 according to relative valuation methord.
What is Personalis Inc (PSNL) fair value?
How does PSNL's valuation metrics compare to the industry average?
What is the current P/B ratio for Personalis Inc (PSNL) as of May 21 2025?
What is the current FCF Yield for Personalis Inc (PSNL) as of May 21 2025?
What is the current Forward P/E ratio for Personalis Inc (PSNL) as of May 21 2025?